This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medimmune Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Martin Michael Kari Schwickart: Innovator in Rheumatoid Arthritis Treatment
Introduction
Martin Michael Kari Schwickart is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of medical diagnostics, particularly in the treatment of rheumatoid arthritis. His innovative work focuses on the use of anti-PAD4 autoantibodies as clinical response biomarkers.
Latest Patents
Schwickart holds a patent for "Anti-PAD4 autoantibodies as clinical response biomarkers for the treatment of rheumatoid arthritis." This patent outlines the use of anti-PAD4 autoantibodies as a clinical biomarker for rheumatoid arthritis (RA) treatment. The disclosure also includes an assay to detect these autoantibodies, assay kits for their detection, and computer-implemented diagnostic methods. He has 1 patent to his name.
Career Highlights
Currently, Schwickart is associated with MedImmune Limited, where he continues to advance research in the field of immunology and diagnostics. His work has the potential to improve treatment outcomes for patients suffering from rheumatoid arthritis.
Collaborations
Some of his notable coworkers include Rachel Patricia Moate and Alex Godwood, who contribute to the innovative environment at MedImmune Limited.
Conclusion
Martin Michael Kari Schwickart is a key figure in the development of diagnostic methods for rheumatoid arthritis, with a focus on anti-PAD4 autoantibodies. His contributions are paving the way for improved clinical practices in the treatment of this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile